A comprehensive view of OPKO Health Inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Labcorp to acquire selected assets of BioReference Health from OPKO Health focused on clinical diagnostics and reproductive and women's health in the US outside of New York and New Jersey for US$237.5M; acquisition expected to close in H2 2024
Published: March 28, 2024 by Laboratory Corp. of America Holdings (LabCorp)
FDA approves Pfizer and OPKO's NGENLA somatrogon-ghla once-weekly injectable for pediatric growth hormone deficiencies; it's estimated GHD affects one in approximately 4,000 to 10,000 children
Published: June 28, 2023 by Business Wire

Ask us about our Health Care Sector market view

Trending Chart

Interactive chart with headline count